Factor Therapeutics Limited reported earnings results for the half year to 30 June 2021. For the period, the company reported Net loss after tax of AUD 184,503 or 0.02 cents per basic and diluted share against profit of AUD 627,348 or 0.06 cents per basic and diluted share a year ago.